Table of Contents

Original Article

• You have access

  Cyclophosphamide abrogates the expansion of CD4⁺Foxp3⁺ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas

  Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen

  Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027
• You have access

  EZH2 identifies the precursors of human natural killer cells with trained immunity

  Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren

  Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
• You have access

  The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms

  Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang

  Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450
• You have access

  Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers

  Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye

  Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022
• You have access

  Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies

  Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao

  Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040
• You have access

  Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types

  Zhe Gong, Yue Yang, Jieyun Zhang and Weijian Guo

  Cancer Biology & Medicine November 2021, 18 (4) 1080-1091; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0351
• You have access

  Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver

  Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun

  Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278
• You have access

  Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events

  Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren

  Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
• You have access

  Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events

  Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui

  Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052
• You have access

  The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma

  Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei

  Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023